Target engagement without clinical benefit: a systematic review, mechanism-concordant meta-analysis, and research agenda for Parkinson’s disease immunotherapy

Xingli Zhou, Seidu A. Richard, Zhigang Lan, Sharma Madhusudan, Rui Zhang

Open source

DOI
10.1080/1750743x.2026.2756119
Published
2026-11-06
Container
Immunotherapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/1750743x.2026.2756119,
  title = {Target engagement without clinical benefit: a systematic review, mechanism-concordant meta-analysis, and research agenda for Parkinson’s disease immunotherapy},
  author = {Xingli Zhou and Seidu A. Richard and Zhigang Lan and Sharma Madhusudan and Rui Zhang},
  year = {2026},
  journal = {Immunotherapy},
  doi = {10.1080/1750743x.2026.2756119},
  url = {https://doi.org/10.1080/1750743x.2026.2756119}
}

RIS

TY  - JOUR
TI  - Target engagement without clinical benefit: a systematic review, mechanism-concordant meta-analysis, and research agenda for Parkinson’s disease immunotherapy
AU  - Xingli Zhou
AU  - Seidu A. Richard
AU  - Zhigang Lan
AU  - Sharma Madhusudan
AU  - Rui Zhang
PY  - 2026
JO  - Immunotherapy
DO  - 10.1080/1750743x.2026.2756119
UR  - https://doi.org/10.1080/1750743x.2026.2756119
ER  - 

APA

Zhou, X., Richard, S. A., Lan, Z., Madhusudan, S., & Zhang, R. (2026). Target engagement without clinical benefit: a systematic review, mechanism-concordant meta-analysis, and research agenda for Parkinson’s disease immunotherapy. Immunotherapy. https://doi.org/10.1080/1750743x.2026.2756119

Source records